PureTech Health FY 2023 GAAP EPS $(0.24) Beats $(0.93) Estimate, Sales $3.330M Down From $15.618M YoY
PureTech Health FY 2023 GAAP EPS $(0.24) Beats $(0.93) Estimate, Sales $3.330M Down From $15.618M YoY
PureTech Health 2023財年GAAP每股收益美元（0.24美元）超過預期（0.93美元），銷售額爲333萬美元，低於同比156.18億美元
PureTech Health (NASDAQ:PRTC) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.93) by 74.19 percent. The company reported $3.330 million in sales this quarter. This is a 78.68 percent decrease over sales of $15.618 million the same period last year.
PureTech Health（納斯達克股票代碼：PRTC）公佈的季度虧損爲每股0.24美元，比分析師普遍預期的0.93美元（0.93美元）高出74.19％。該公司報告本季度銷售額爲3330萬美元。這比去年同期的1561.8萬美元的銷售額下降了78.68％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。